argenx at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

argenx at BIO-Europe 2026 in Cologne: 1 session (1 keynote).

OrganizationBIO-Europe 2026 Attendance
argenx.com
Large pharma
Immunology company developing and selling antibody therapies for autoimmune diseases, including Vyvgart for generalized myasthenia gravis.
Keynote
Mon Nov 9
12:00–12:45
Building a competitive and impactful European biotech community: Perspectives from the European Life Sciences Coalition and CEOs
How Europe can keep biotech talent, money and companies at home by drawing in big investors, speeding regulation and building stronger stock markets.
with Evaluate, Angelini Ventures, Andera Partners +1 more
Ecosystem InnovationBusiness of Biotech

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from argenx

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction